{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:23:15Z","timestamp":1790346195157,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Cardiologie et d'Ang\u00e9iologie"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.ancard.2017.10.011","type":"journal-article","created":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T04:46:48Z","timestamp":1509079608000},"page":"385-392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Le diab\u00e8te, une pathologie prothrombotique"],"prefix":"10.1016","volume":"66","author":[{"given":"F.","family":"Picard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Adjedj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Varenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ancard.2017.10.011_bib0005","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","article-title":"Global estimates of diabetes prevalence for 2013\u00a0and projections for 2035","volume":"103","author":"Guariguata","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.ancard.2017.10.011_bib0010","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1161\/01.CIR.0000089189.70578.E2","article-title":"Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II","volume":"108","author":"L\u00fcscher","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ancard.2017.10.011_bib0015","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1161\/CIRCULATIONAHA.107.720847","article-title":"Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3\u00a0million people","volume":"117","author":"Schramm","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ancard.2017.10.011_bib0020","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nrcardio.2010.35","article-title":"Intensive glycemic control and cardiovascular disease: an update","volume":"7","author":"Brown","year":"2010","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ancard.2017.10.011_bib0025","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.2337\/diabetes.54.8.2430","article-title":"Platelet function profiles in patients with type 2\u00a0diabetes and coronary artery disease on combined aspirin and clopidogrel treatment","volume":"54","author":"Angiolillo","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.ancard.2017.10.011_bib0030","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.2337\/diacare.24.8.1476","article-title":"Platelet dysfunction in type 2\u00a0diabetes","volume":"24","author":"Vinik","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ancard.2017.10.011_bib0035","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s001250051598","article-title":"Regulation of protein kinase C by short term hyperglycaemia in human platelets in vivo and in vitro","volume":"44","author":"Assert","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.ancard.2017.10.011_bib0040","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1055\/s-0038-1646320","article-title":"Decreased platelet membrane fluidity due to glycation or acetylation of membrane proteins","volume":"68","author":"Winocour","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ancard.2017.10.011_bib0045","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s001250051135","article-title":"Alterations in platelet Ca2+ signalling in diabetic patients is due to increased formation of superoxide anions and reduced nitric oxide production","volume":"42","author":"Schaeffer","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/j.ancard.2017.10.011_bib0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12933-015-0182-7","article-title":"The effect of clopidogrel on platelet activity in patients with and without type-2\u00a0diabetes mellitus: a comparative study","volume":"14","author":"Schuette","year":"2015","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ancard.2017.10.011_bib0055","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1016\/j.jacc.2008.07.068","article-title":"Patients with poor responsiveness to thienopyridine treatment or with diabetes have lower levels of circulating active metabolite, but their platelets respond normally to active metabolite added ex vivo","volume":"52","author":"Erlinge","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ancard.2017.10.011_bib0060","doi-asserted-by":"crossref","first-page":"e000296","DOI":"10.1136\/openhrt-2015-000296","article-title":"Systematic review and meta-analysis of optimal P2Y12\u00a0blockade in dual antiplatelet therapy for patients with diabetes with acute coronary syndrome","volume":"3","author":"Rossington","year":"2016","journal-title":"Open Heart"},{"key":"10.1016\/j.ancard.2017.10.011_bib0065","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1160\/TH10-02-0082","article-title":"24-hour time-dependent aspirin efficacy in patients with stable coronary artery disease","volume":"105","author":"Henry","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ancard.2017.10.011_bib0070","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.2337\/db07-0707","article-title":"The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study","volume":"56","author":"DiChiara","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.ancard.2017.10.011_bib0075","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1001\/archinte.167.15.1593","article-title":"Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis","volume":"167","author":"Snoep","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ancard.2017.10.011_bib0080","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.ahj.2012.06.008","article-title":"Biological efficacy of twice daily aspirin in type 2\u00a0diabetic patients with coronary artery disease","volume":"164","author":"Dillinger","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.ancard.2017.10.011_bib0085","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1210\/edrv.22.1.0417","article-title":"Diabetes and endothelial dysfunction: a clinical perspective","volume":"22","author":"Calles-Escandon","year":"2001","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ancard.2017.10.011_bib0090","doi-asserted-by":"crossref","first-page":"940","DOI":"10.2174\/092986709787581888","article-title":"Soluble forms of RAGE in human diseases: clinical and therapeutical implications","volume":"16","author":"Santilli","year":"2009","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.ancard.2017.10.011_bib0095","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.freeradbiomed.2007.06.017","article-title":"Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins","volume":"43","author":"Santilli","year":"2007","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.ancard.2017.10.011_bib0100","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.freeradbiomed.2007.03.015","article-title":"Soluble RAGE in type 2\u00a0diabetes: association with oxidative stress","volume":"43","author":"Devangelio","year":"2007","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.ancard.2017.10.011_bib0105","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1161\/CIRCULATIONAHA.105.563213","article-title":"Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms","volume":"113","author":"Kim","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ancard.2017.10.011_bib0110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/cvr\/cvq412","article-title":"Nitric oxide: a key factor behind the dysfunctionality of endothelial progenitor cells in diabetes mellitus type-2","volume":"91","author":"Hamed","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ancard.2017.10.011_bib0115","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2796.2007.01824.x","article-title":"Diabetes mellitus as a prothrombotic condition","volume":"262","author":"Grant","year":"2007","journal-title":"J Intern Med"},{"key":"10.1016\/j.ancard.2017.10.011_bib0120","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1177\/1479164110383723","article-title":"Coagulation and fibrinolysis in diabetes","volume":"7","author":"Alzahrani","year":"2010","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.ancard.2017.10.011_bib0125","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.2337\/diabetes.48.5.1156","article-title":"Activation of the tissue factor pathway of blood coagulation during prolonged hyperglycemia in young healthy men","volume":"48","author":"Rao","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.ancard.2017.10.011_bib0130","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1161\/01.CIR.94.9.2171","article-title":"Circulating levels of factor VII, fibrinogen, and von Willebrand factor and features of insulin resistance in first-degree relatives of patients with NIDDM","volume":"94","author":"Mansfield","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ancard.2017.10.011_bib0135","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/1056-8727(92)90042-J","article-title":"Thrombin-antithrombin III complexes in type II diabetes mellitus","volume":"6","author":"Dav\u00ec","year":"1992","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.ancard.2017.10.011_bib0140","first-page":"1307","article-title":"Blood thrombogenicity in type 2\u00a0diabetes mellitus patients is associated with glycemic control","volume":"38","author":"Osende","year":"2001","journal-title":"Jac"},{"key":"10.1016\/j.ancard.2017.10.011_bib0145","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.thromres.2006.10.016","article-title":"Glycation of fibrinogen in uncontrolled diabetic patients and the effects of glycaemic control on fibrinogen glycation","volume":"120","author":"Pieters","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.ancard.2017.10.011_bib0150","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00125-011-2301-7","article-title":"A novel mechanism for hypofibrinolysis in diabetes: the role of complement C3","volume":"55","author":"Hess","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.ancard.2017.10.011_bib0155","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1007\/s00125-005-1742-2","article-title":"The influence of type 2\u00a0diabetes on fibrin structure and function","volume":"48","author":"Dunn","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.ancard.2017.10.011_bib0160","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1160\/TH07-11-0699","article-title":"Glycaemic control improves fibrin network characteristics in type 2\u00a0diabetes\u00a0\u2014\u00a0a purified fibrinogen model","volume":"99","author":"Pieters","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ancard.2017.10.011_bib0165","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1111\/j.1538-7836.2010.03910.x","article-title":"Hyperglycemia: a prothrombotic factor?","volume":"8","author":"Lemkes","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ancard.2017.10.011_bib0170","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.2337\/dc13-1776","article-title":"Increased incorporation of antiplasmin into the fibrin network in patients with type 1\u00a0diabetes","volume":"37","author":"Agren","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ancard.2017.10.011_bib0175","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1182\/blood-2013-04-494641","article-title":"Diabetes is associated with posttranslational modifications in plasminogen resulting in reduced plasmin generation and enzyme-specific activity","volume":"122","author":"Ajjan","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ancard.2017.10.011_bib0180","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1160\/TH16-03-0176","article-title":"Microparticles as new markers of cardiovascular risk in diabetes and beyond","volume":"116","author":"Santilli","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ancard.2017.10.011_bib0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5551\/jat.32326","article-title":"Microparticle and atherothrombotic diseases","volume":"23","author":"Nomura","year":"2016","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.ancard.2017.10.011_bib0190","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2\u00a0diabetes as an inflammatory disease","volume":"11","author":"Donath","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ancard.2017.10.011_bib0195","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2147\/ITT.S73223","article-title":"The role of adipokines in chronic inflammation","volume":"5","author":"Mancuso","year":"2016","journal-title":"Immunotargets Ther"},{"key":"10.1016\/j.ancard.2017.10.011_bib0200","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1160\/TH13-02-0179","article-title":"Role of plasma kallikrein in diabetes and metabolism","volume":"110","author":"Feener","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ancard.2017.10.011_bib0205","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1097\/CCM.0b013e3182653269","article-title":"Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients","volume":"40","author":"Jacobi","year":"2012","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ancard.2017.10.011_bib0210","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1016\/j.ehj.2004.07.027","article-title":"The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart","volume":"25","author":"Bartnik","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ancard.2017.10.011_bib0215","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1093\/eurheartj\/ehl271","article-title":"Is admission hyperglycaemia in non-diabetic patients with acute myocardial infarction a surrogate for previously undiagnosed abnormal glucose tolerance?","volume":"27","author":"Ishihara","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ancard.2017.10.011_bib0220","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/BF00265372","article-title":"Blood glucose may condition factor VII levels in diabetic and normal subjects","volume":"31","author":"Ceriello","year":"1988","journal-title":"Diabetologia"},{"key":"10.1016\/j.ancard.2017.10.011_bib0225","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1182\/blood-2007-11-121723","article-title":"Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia","volume":"112","author":"Stegenga","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ancard.2017.10.011_bib0230","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2337\/diabetes.55.01.06.db05-1026","article-title":"Effects of hyperglycemia and hyperinsulinemia on circulating tissue factor procoagulant activity and platelet CD40\u00a0ligand","volume":"55","author":"Vaidyula","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.ancard.2017.10.011_bib0235","first-page":"57","article-title":"Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1\u00a0year","volume":"26","author":"Malmberg","year":"1995","journal-title":"Jac"},{"key":"10.1016\/j.ancard.2017.10.011_bib0240","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa011300","article-title":"Intensive insulin therapy in critically ill patients","volume":"345","author":"van den Berghe","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ancard.2017.10.011_bib0245","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1056\/NEJMoa1204942","article-title":"Hypoglycemia and risk of death in critically ill patients","volume":"367","author":"NICE-SUGAR Study Investigators","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ancard.2017.10.011_bib0250","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S2213-8587(15)00223-5","article-title":"Glucose management in critically ill adults and children","volume":"3","author":"Mesotten","year":"2015","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Annales de Cardiologie et d'Ang\u00e9iologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003392817301427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003392817301427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T06:52:24Z","timestamp":1570258344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003392817301427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0003392817301427"],"URL":"https:\/\/doi.org\/10.1016\/j.ancard.2017.10.011","relation":{},"ISSN":["0003-3928"],"issn-type":[{"value":"0003-3928","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Le diab\u00e8te, une pathologie prothrombotique","name":"articletitle","label":"Article Title"},{"value":"Annales de Cardiologie et d'Ang\u00e9iologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ancard.2017.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}